Dr. Lakshmy Mathur Vythilingam, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2430 W Pierce St, Carlsbad, NM 88220 Phone: 575-887-4504 Fax: 575-628-5080 |
David Robillard, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2410 W Pierce St, Carlsbad, NM 88220 Phone: 505-885-0766 |
Murugan Athigaman, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2402 W Pierce St Ste 5c, Carlsbad, NM 88220 Phone: 575-725-5755 Fax: 575-725-5753 |
News Archive
A new study links progression of a lethal type of brain tumor with reduced expression of more than 600 immune system genes, suggesting how complex the immune response is to the cancer and the resulting difficulty in targeting specific immune system proteins for treatment.
NanoViricides, Inc. has said that in a confirmatory study, their nanoviricide drug candidates exhibited a consistent 20% to 30% survival in the test animals.
From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new therapeutic strategies and nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.
According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI), a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS), also reduces vision loss in patients with relapsing MS.
› Verified 2 days ago